HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liyang Ji Selected Research

secretogranin III

1/2022Secretogranin III stringently regulates pathological but not physiological angiogenesis in oxygen-induced retinopathy.
1/2022Comparative ligandomics implicates secretogranin III as a disease-restricted angiogenic factor in laser-induced choroidal neovascularization.
1/2022Selectively targeting disease-restricted secretogranin III to alleviate choroidal neovascularization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Liyang Ji Research Topics

Disease

2Choroidal Neovascularization
01/2022 - 01/2022
2Diabetic Retinopathy (Retinopathy, Diabetic)
01/2022 - 08/2021
1Retinopathy of Prematurity (Retrolental Fibroplasia)
01/2022
1Retinal Diseases
01/2022
1Pathologic Neovascularization
01/2022
1Blindness (Hysterical Blindness)
01/2022
1Neoplasms (Cancer)
01/2020
1Eye Diseases (Eye Disease)
01/2020
1Cataract (Cataracts)
01/2020

Drug/Important Bio-Agent (IBA)

3secretogranin IIIIBA
01/2022 - 01/2022
3Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2022 - 01/2022
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 01/2022
1afliberceptIBA
01/2022
1phosphatidylethanolamineIBA
01/2020
1Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2020

Therapy/Procedure

2Therapeutics
08/2021 - 01/2020
1Lasers (Laser)
01/2022